Clear Creek Financial Management LLC lowered its stake in RTX Co. (NYSE:RTX – Free Report) by 11.5% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,181 shares of the company’s stock after selling 284 shares during the quarter. Clear Creek Financial Management LLC’s holdings in RTX were worth $264,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Briaud Financial Planning Inc grew its holdings in RTX by 64.1% during the 2nd quarter. Briaud Financial Planning Inc now owns 256 shares of the company’s stock valued at $25,000 after buying an additional 100 shares in the last quarter. Lynx Investment Advisory purchased a new position in shares of RTX in the second quarter valued at $26,000. Mizuho Securities Co. Ltd. bought a new stake in RTX in the second quarter worth $32,000. Fairfield Financial Advisors LTD purchased a new stake in RTX during the second quarter valued at $41,000. Finally, ORG Wealth Partners LLC bought a new position in RTX during the third quarter valued at $50,000. Institutional investors own 86.50% of the company’s stock.
RTX Stock Performance
RTX stock opened at $118.00 on Tuesday. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.73 and a current ratio of 0.99. The company has a market capitalization of $157.06 billion, a PE ratio of 33.71, a P/E/G ratio of 2.14 and a beta of 0.82. The company has a 50 day moving average price of $122.13 and a 200-day moving average price of $112.17. RTX Co. has a fifty-two week low of $78.00 and a fifty-two week high of $128.70.
RTX Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 12th. Investors of record on Friday, November 15th will be issued a dividend of $0.63 per share. This represents a $2.52 annualized dividend and a yield of 2.14%. The ex-dividend date is Friday, November 15th. RTX’s payout ratio is 72.00%.
Analyst Ratings Changes
Several analysts have recently issued reports on the stock. StockNews.com upgraded shares of RTX from a “hold” rating to a “buy” rating in a research report on Friday, September 6th. Bank of America raised RTX from a “neutral” rating to a “buy” rating and raised their price objective for the company from $110.00 to $140.00 in a research note on Wednesday, July 31st. Morgan Stanley boosted their target price on RTX from $120.00 to $130.00 and gave the company an “equal weight” rating in a research report on Wednesday, October 23rd. UBS Group raised their price target on RTX from $126.00 to $133.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 23rd. Finally, Barclays boosted their price objective on shares of RTX from $108.00 to $130.00 and gave the company an “equal weight” rating in a research report on Tuesday, October 29th. Ten equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, RTX currently has a consensus rating of “Hold” and an average price target of $177.27.
Check Out Our Latest Stock Report on RTX
About RTX
RTX Corporation, an aerospace and defense company, provides systems and services for the commercial, military, and government customers in the United States and internationally. It operates through three segments: Collins Aerospace, Pratt & Whitney, and Raytheon. The Collins Aerospace Systems segment offers aerospace and defense products, and aftermarket service solutions for civil and military aircraft manufacturers and commercial airlines, as well as regional, business, and general aviation, defense, and commercial space operations.
Featured Stories
- Five stocks we like better than RTX
- 3 Stocks to Consider Buying in October
- Intel: Is Now the Time to Be Brave?Â
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Where Do I Find 52-Week Highs and Lows?
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Want to see what other hedge funds are holding RTX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for RTX Co. (NYSE:RTX – Free Report).
Receive News & Ratings for RTX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTX and related companies with MarketBeat.com's FREE daily email newsletter.